FinBoss.io
CSEN
  • Home
  • Crypto prices
  • Bitcoin on-chain
  • US macro
  • US stocks
  • Guides
  • How we make money
FinBoss.io
Home
Crypto prices
Bitcoin on-chain
Hashrate
Mining difficulty
Mining pools
Mempool and fees
On-chain activity
MVRV and NUPL
SOPR
Holders
Supply in profit
Rainbow Chart
Fair value
Pi Cycle Top
US macro
FedWatch
Interest rates
Treasury yields
Inflation
Liquidity and Bitcoin
Business cycle
US stocks
Stock screener
Earnings calendar
Insider trading
Market heatmap
Guides
How we make money
CSEN
Home
Stocks
CVS Health Corp
CV

CVS Health Corp

CVSHealth care

Stock · Data from SEC EDGAR 13F · Held by 22 of 87 tracked investors

$93.47
▼ 1.07%
Famous investorshold 22buying 1selling 0
Price (USD)
$93.47
Market cap
$120B
P/E ratio
24.6
Tracked investors holding
22 of 87
Next earnings
4 Nov 2026

CVS Health Corp at a glance

An overview of the financial statements, in plain language. Switch to the advanced view for charts.

FinBoss score
55out of 100
  • Valuation59
  • Growth64
  • Profitability33
  • Quality36
  • Debt36
  • Stability99
In its favour
  • The analysts' average target is 24% above the price.

Earnings results

QuarterReportedEPSAnalyst estimateSurprise
Jun 20265 Aug 20262.581.87+38%
Mar 20266 May 20262.572.21+16.3%
Dec 202510 Feb 20261.090.99+10.1%
Sep 202529 Oct 20251.601.36+17.7%

EPS is earnings per share. The surprise is the difference against the analysts' consensus. Source: Nasdaq, in dollars.

7D
+1.20%
1M
+9.90%
3M
-13.24%
YTD
+16.65%
1Y
+14.09%
3Y
+41.00%
5Y
+4.69%
Forward P/E
11
Dividend yield
2.82%
52-week low
$69.51
52-week high
$110.68

Chart CVS

Insider purchases

last 90 days, SEC Form 4
Loading insider trades…

Which investors hold this stock

22
PW
Prem Watsa
Fairfax Financial Holdings
10.63%$280,502,160unchanged
LR
Larry Robbins
Glenview Capital
9.09%$499,125,457▼ -41.1%
CD
Chris Davis
Davis Advisors
5.27%$1,227,594,458▼ -3.1%
SM
Samantha McLemore
Patient Capital Management
4.19%$127,813,106▼ -9%
RP
Richard Pzena
Pzena Investment Management
3.57%$1,217,558,500▼ -14.5%
AH
Andreas Halvorsen
Viking Global Investors
1.08%$378,974,695New position
JR
John Rogers
Ariel Investments
0.75%$75,529,880▲ +4%
SC
Steven Cohen
Point72 Asset Management
0.22%$202,868,760New position
RD
Ray Dalio
Bridgewater Associates
0.19%$45,618,553▼ -28.7%
Ns
Norský státní fond
Norges Bank
0.19%$1,866,126,481New position
Šn
Švýcarská národní banka
Swiss National Bank
0.19%$371,195,152▼ -3.7%
Čn
Česká národní banka
Česká národní banka
0.17%$31,489,276▲ +1.2%
JG
Joel Greenblatt
Gotham Asset Management
0.11%$48,092,353▲ +137.1%
CA
Cliff Asness
AQR Capital Management
0.09%$248,935,930▲ +1%
MG
Mario Gabelli
GAMCO Investors
0.09%$9,695,127▲ +0.5%
IE
Israel Englander
Millennium Management
0.08%$223,951,974▲ +1,013.6%
JS
Jim Simons
Renaissance Technologies
0.06%$45,623,105▲ +67.6%
KG
Ken Griffin
Citadel Advisors
0.06%$497,856,229▼ -11.3%
GI
Generali Investments CEE
Generali Investments CEE
0.06%$1,189,675unchanged
BN
Bill Nygren
Oakmark (Harris Associates)
0.05%$34,740,269▼ -32%
PT
Paul Tudor Jones
Tudor Investment Corp
0.05%$38,276,500▼ -45.7%
KF
Ken Fisher
Fisher Investments
0%$9,518,507▲ +4.1%

Frequently asked questions

How much is CVS Health Corp (CVS) stock?

CVS Health Corp shares trade at $93.47, -1.07% over the last trading day. The price is delayed.

What is the market cap of CVS Health Corp?

The market cap of CVS Health Corp is about $120B and its price-to-earnings ratio (P/E) is 24.6.

Does CVS Health Corp pay a dividend?

The dividend yield of CVS Health Corp is 2.82% a year. The yield can change with the company's decisions.

How has CVS Health Corp stock performed over the last year?

The CVS Health Corp share price changed by +14.09% over 12 months and by +4.69% over 5 years.

Which big investors hold CVS Health Corp?

According to the latest 13F filings, 22 of 87 tracked investors hold CVS Health Corp, for example Prem Watsa, Larry Robbins, Chris Davis.

When will CVS Health Corp report its next results?

The next earnings report of CVS Health Corp is expected on 4 Nov 2026.

Source: SEC EDGAR 13F-HR (quarterly filings). The data is indicative and is not investment advice.

© 2026 FinBoss.io. All rights reserved.

How we make moneyTerms (Czech)Privacy (Czech)Cookies (Czech)

Disclaimer: the information on this site is for general information only and is not investment or financial advice. Investing involves risk, and cryptocurrencies are especially volatile. Past performance does not guarantee future results. Some links are affiliate links and are marked as ads.

✓
What to watch
  • !Out of 100 USD of revenue, only 1.2 USD is left as net profit.
  • !Net debt is high: at the current free cash flow it would take 7.7 years to repay.

The score describes the quality and the past of the company based on its statements (the FinBoss model, indicative). A high score is not a buy signal and a low one is not a sell signal. Data source: Yahoo Finance, prices and statements in USD.

Is the stock expensive?

Reasonably priced

For 1 USD of annual earnings you pay 24.6 USD. Based on next year's estimates 11.0 USD.

P/E
24.6×
P/S
0.3×
EV/EBITDA
10.9×

Is the company growing?

Growing slowly
22
23
24
25

Revenue over 3 years grew 7.6% a year. Last year 7.1%.

Does it make money?

Weak
  • Cost of sales 86
  • Research 0.0
  • Operations and selling 11.2
  • Taxes and other 2.1
  • Net profit 0.4

Out of 100 USD of revenue, 0.4 USD is left as net profit.

Is it financially healthy?

Watch the debt
Cash
14.0B USD
Debt
76.3B USD
Free CF
8.1B USD

It could repay its net debt from free cash flow in 7.7 years.

Does it pay a dividend?

Pays
Yield
2.82%
Of earnings
70%

Over a year you receive roughly 2.82% of the price per share. The payout is more demanding for the company.

What do analysts expect?

Strong buy
Average target
115.48 USD
Vs price
+24%

25 analysts. Their opinion is not a recommendation by FinBoss.io.

Which big investors hold it?

22 of 87

Among the tracked investors, Prem Watsa, Larry Robbins, Chris Davis and others hold the stock according to 13F filings.

Revenue and net profit (USD B)

Margins (% of revenue)

Free cash flow and capex (USD B)

Cash and debt (USD B)

Earnings per share (EPS, USD)

Latest quarters (USD B)

Dividend per share by year (USD)

* the year has not ended yet. Source: Yahoo Finance.

Ratios

P/E
24.6×
Forward P/E
11.0×
P/B
1.5×
P/S
0.3×
PEG
0.22
EV/EBITDA
10.9×
Gross margin
13.6%
Operating margin
3.9%
Net margin
1.2%
ROE
6.2%
ROA
3.0%
Debt / equity
1.0×
Current ratio
0.9×
Revenue growth
7.1%
Earnings growth
188.8%
Beta
0.60
Dividend
2.82%
Payout ratio
70%